Endo Pharmaceuticals Solutions Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 246

Employees

  • Latest Deal Type
  • M&A

Endo Pharmaceuticals Solutions General Information

Description

Operator of a biotechnology platform designed to develop and commercialize specialty pharmaceutical. The company's biotechnology platform develops and commercializes specialty pharmaceuticals through internal research and development and strategic partnerships is advancing the state-of-art of drug delivery with its innovative Hydron Implant technology, enabling physicians to treat conditions in urology and endocrinology.

Contact Information

Formerly Known As
Indevus Pharmaceuticals, Interneuron Pharmaceuticals
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Endo Boulevard
  • Chadds Ford, PA 19317
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Asana BioSciences
Vertical(s)
Life Sciences
Corporate Office
  • 100 Endo Boulevard
  • Chadds Ford, PA 19317
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endo Pharmaceuticals Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 02-Jun-2014 Completed Generating Revenue
3. Merger/Acquisition 05-Jan-2009 Completed Generating Revenue
2. IPO 08-Mar-1990 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Endo Pharmaceuticals Solutions’s complete valuation and funding history, request access »

Endo Pharmaceuticals Solutions Patents

  • 394

    Total Documents Applications and Grants

  • Total Patents Families

  • 89

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Endo Pharmaceuticals Solutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014160167-A1 Implantable drug delivery compositions comprising aromatic polyurethanes and methods of treatment thereof Inactive 14-Mar-2013
WO-2014160155-A2 Implantable drug delivery compositions comprising non-polymeric sorption enhancers and methods of treatment thereof Inactive 14-Mar-2013
WO-2014160155-A3 Implantable drug delivery compositions comprising non-polymeric sorption enhancers and methods of treatment thereof Inactive 14-Mar-2013
WO-2014160026-A2 Implantable drug delivery compositions comprising sugar-based sorption enhancers and methods of treatment thereof Inactive 14-Mar-2013
WO-2014160026-A3 Implantable drug delivery compositions comprising sugar-based sorption enhancers and methods of treatment thereof Inactive 14-Mar-2013 A61K9/0024
To view Endo Pharmaceuticals Solutions’s complete patent history, request access »

Endo Pharmaceuticals Solutions Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endo Pharmaceuticals Solutions Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Endo International Corporation Majority
Tech Council Ventures Venture Capital Minority
To view Endo Pharmaceuticals Solutions’s complete investors history, request access »

Ready to get started?

Request a free trial

Endo Pharmaceuticals Solutions FAQs

  • When was Endo Pharmaceuticals Solutions founded?

    Endo Pharmaceuticals Solutions was founded in 1988.

  • Where is Endo Pharmaceuticals Solutions headquartered?

    Endo Pharmaceuticals Solutions is headquartered in Chadds Ford, PA.

  • What is the size of Endo Pharmaceuticals Solutions?

    Endo Pharmaceuticals Solutions has 246 total employees.

  • What industry is Endo Pharmaceuticals Solutions in?

    Endo Pharmaceuticals Solutions’s primary industry is Pharmaceuticals.

  • Is Endo Pharmaceuticals Solutions a private or public company?

    Endo Pharmaceuticals Solutions is a Private company.

  • What is Endo Pharmaceuticals Solutions’s current revenue?

    The current revenue for Endo Pharmaceuticals Solutions is .

  • Who are Endo Pharmaceuticals Solutions’s investors?

    Endo International and Tech Council Ventures have invested in Endo Pharmaceuticals Solutions.

  • When was Endo Pharmaceuticals Solutions acquired?

    Endo Pharmaceuticals Solutions was acquired on 02-Jun-2014.

  • Who acquired Endo Pharmaceuticals Solutions?

    Endo Pharmaceuticals Solutions was acquired by Asana BioSciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process